CrystalO Biopharma
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- Undisclosed
Investors
- 4
About CrystalO Biopharma
Established in 2019 and based in Shenzhen, China, CrystalO Biopharma operates an innovative drug developer that specializes in the research and development of innovative ion channel drugs for mental illness and chronic kidney disease. The company's core team comes from Harvard University, Shanghai Institute of Materia Medica and other research institutes and pharmaceutical companies. The company acquired the 2020 China Science and Technology Innovation Pioneer Technology Award and Shenzhen Specialized, Refined, Featured and Original SME. CrystalO Biopharma focuses on the research and development of membrane proteins including ion channels and GPCRs for major diseases such as chronic kidney disease and mental illness. Its products include GPCRs (G protein-coupled receptors), ion channels, anti-COVID-19 protein products, soluble proteins, nanodisc-assembled membrane proteins, etc. The company has established ion channel target small molecule and protein drug technology platforms, IonFire platform and BigC platform. It has also developed high-stability antigen production platform, structure-based drug design platform, structural biology platform, multi-specific nanoantibody platform and other biotechnology platforms, and provides customers with services such as COVID-19 recombinant protein and structural analysis, drug target structure analysis, etc. The company generates revenue by providing innovative ion channel drugs for neuropsychiatric diseases and chronic kidney disease. The company will accelerate the advancement of its core pipeline and upgrade its technology platform.
Who invested in CrystalO Biopharma
4 investors across 3 rounds
See all investors in CrystalO Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CrystalO Biopharma
Who invested in CrystalO Biopharma?
CrystalO Biopharma has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CrystalO Biopharma raised?
CrystalO Biopharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CrystalO Biopharma last raise money?
CrystalO Biopharma's most recent round on record is a Series A, in Mar 2025.
What does CrystalO Biopharma do?
Established in 2019 and based in Shenzhen, China, CrystalO Biopharma operates an innovative drug developer that specializes in the research and development of innovative ion channel drugs for mental illness and chronic kidney disease.
Where is CrystalO Biopharma headquartered?
CrystalO Biopharma is headquartered in Shenzhen, China.
Which VCs invest in companies like CrystalO Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at CrystalO Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CrystalO Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.